S-4/A XBRL

AMENDMENT NO 1 TO REGISTRATION STATEMENT

Company: ZyVersa Therapeutics, Inc.
Filed: September 27, 2022
Accession Number: 0001213900-22-059148

View Document ↗ View on SEC.gov ↗